33 results
8-K
IMPLQ
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
and restructuring strategy, the management of critical relationships and retention of experts, and such other duties as may be necessary or advisable in the course … (the “Paolillo Advance”), his retention of which is subject to his continued employment until the earlier of (A) the closing of a Corporate Transaction
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
been achieved. Purchaser shall keep, for so long as required under Purchaser’s internal records retention policies, books and records pertaining
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
14 Nov 23
Departure of Directors or Certain Officers
4:01pm
set forth in the New Retention Program for each Participant that is entered into between each Participant and the Company on or about the adoption date
424B5
IMPLQ
Impel Pharmaceuticals Inc
5 Oct 23
Prospectus supplement for primary offering
5:19pm
Officer. Although we have entered into employment agreements and retention agreements with our executive officers, each of these persons may terminate … in employee and non-employee expenses announced in February 2023, and our ongoing liquidity issues makes retention of our current personnel both more
8-K
EX-10.3
5udbkaafyphbl
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.4
a4jjpb59u ezbddiz
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.1
ghdk9
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
0qshe 4zfxwg1zfq0
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
me43ti27 ehx
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
8-K
EX-10.1
2sk0o0tktbrx6
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
S-3
EX-4.4
kk52s b5yj
16 May 22
Shelf registration
4:49pm
10-K
sgnt1ofi 9ykh1q
29 Mar 22
Annual report
5:09pm